Live Feeds
Press Releases
Insider Trading
FDA Approvals
Analyst Ratings
Insider Trading
SEC filings
Market insights
Analyst Ratings
Alerts
Subscriptions
Settings
RSS Feeds
Live Feeds
Press Releases
Insider Trading
FDA Approvals
Analyst Ratings
Insider Trading
SEC filings
Market insights
Analyst Ratings
Alerts
Subscriptions
Settings
RSS Feeds
Publish
Dashboard
Subscribe to $CLDI
Calidi Biotherapeutics Inc.
Subscribe to $CLDI
$CLDI
Biotechnology: Biological Products (No Diagnostic Substances)
Health Care
IPO Year: 2021
Exchange: AMEX
Recent Analyst Ratings for Calidi Biotherapeutics Inc.
Date
Price Target
Rating
Analyst
11/22/2023
$11.00
Buy
H.C. Wainwright
10/9/2023
$9.00
Outperform
Robert W. Baird
See more ratings
